![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Tilman Roedle
Tilman Roedle is Lead Expert Drug Delivery Systems for Vetter. He deals intensively with strategic industry collaborations on innovative drug delivery systems and Quality Management for medical device development. Tilman joint Vetter in 2003 as Project Manager, Packaging Development and was appointed Director of Packaging Development in 2005. In this position, he was responsible for primary packaging materials for parenterals and drug delivery systems, later including secondary packaging as well as automated visual inspection implementation and process qualification to help ensure cGMP. His career began in 1996 as a Design Engineer in special machinery for the automotive industry, and later worked as a Project Manager for special machinery investment projects. Tilman earned his Master’s Degree in Mechanical Engineering at the University of Stuttgart, Germany, in 1995, focusing his studies on key aspects of design and materials’ sciences.
Company:Vetter
Headquartered in Ravensburg, Germany, Vetter is a family-owned, global leading contract development and manufacturing organization (CDMO) with production facilities in Germany, Austria and the United States. Currently employing more than 5,700 individuals worldwide, the company has long-term experience in supporting biotechnology and pharmaceutical customers both large and small. Vetter services range from early stage development support including clinical manufacturing, to commercial supply and numerous packaging solutions for vials, syringes and cartridges. As a leading solution provider, Vetter appreciates its responsibility to support the needs of its customers by developing devices that contribute to increased patient safety, convenience, and enhanced compliance. Great importance is also given to social responsibility including environmental protection and sustainability. Learn more about Vetter at www.vetter-pharma.com.
